TropIQ

TropIQ Health Sciences is a Dutch biotechnology company dedicated to the discovery and development of novel medicines for infectious diseases, with a specialized focus on malaria and other vector-borne illnesses. The company operates a unique technology platform that integrates a high-throughput screening facility with a sophisticated insectary, enabling the evaluation of compounds across the entire life cycle of parasites and their mosquito vectors. TropIQ functions as both a drug discovery entity and a contract research organization, providing expertise to global pharmaceutical companies and non-profit organizations like the Bill & Melinda Gates Foundation. Their pipeline includes programs aimed at blocking malaria transmission and developing new treatments for the asexual blood stages of the disease. By combining entomological expertise with modern drug discovery techniques, TropIQ aims to accelerate the global effort to eliminate tropical diseases.